Funding · Company
Enlaza Therapeutics, Inc.
La Jolla, CABiotech & Pharma
Enlaza Therapeutics, Inc. of La Jolla, CA has disclosed $119M across 2 Form D offerings filed with the SEC between Nov 22, 2022 and Aug 9, 2024.
$119M
Total disclosed
2
Form D offerings
2020
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$84M
Form D · Aug 9, 2024 ↗
Q3 2024
· target $110M
$35M
Form D · Nov 22, 2022 ↗
Q4 2022
· target $61M
Filing details
HeadquartersLa Jolla, CAIndustryBiotech & Pharma (Pharmaceuticals)Incorporated2020SEC CIK0001852950Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →